Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 246

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 246
---
 meaning of IFRS3, Business Combinations; rather, said part of the Business Combination will be accounted for as a capital reorganization within the framework of a net asset acquisition. See “ Note 3 — Accounting for the Business Combination” for more details. The pro forma combined financial information is for illustrative purposes only. The financial results may have been different had the companies always been combined. You should not rely on the unaudited pro forma combined financial information as being indicative of the historical results that would have been achieved had the companies always been combined or the future results that the Combined Company will experience. SPAC and the Company have not had any intercompany transactions prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between the companies. The historical financial statements of the Company have been prepared in accordance with IFRS as issued by the IASB and in its presentation currency of the U.S. dollar. The historical financial statements of APx have been prepared in accordance with GAAP in its presentation currency of the U.S. dollar. The combined pro forma financial information reflects IFRS, the basis of accounting used by the registrant, OmnigenicsAI, and all material 105

accounting policy differences have been identified in converting APx’s historical financial statements to IFRS in the pro forma section, see “ — GAAP to IFRS conversion of APx’s financial information as of December 31, 2024, for the twelve -month period ended June 30, 2024 and for the six -month period ended December 31, 2024.” The adjustments presented in the unaudited pro forma combined financial information have been identified and presented to provide relevant information necessary for an understanding of the Combined Company after giving effect to the Business Combination. The unaudited pro forma combined financial information has been prepared assuming three alternative levels of redemption of SPAC Ordinary Shares into cash: • Scenario 1 — Assuming no redemptions for cash: This presentation assumes that no SPAC Shareholders exercise redemption rights with respect to their SPAC Ordinary Shares upon consummation of the Business Combination and assumes that the obligations under the Backstop Agreement will be satisfied by making a cash contribution in an amount of up to $10,000,000 to OmnigenicsAI Corp. See “ Certain Agreements Related to the Business Combination — Backstop Agreement;” • Scenario 2 — Assuming redemptions of 50% of the outstanding Public Shares for cash: This presentation assumes